118th Congress · SENATE BILLBILL

S. 2683AMERICAN DRUGS Act

A bill to establish requirements for purchasing certain generic drugs from manufacturers who produce the drug domestically.

Health
Introduced Jul 27, 2023
Last action Jul 27, 2023
Pipeline · Bill → Law
Step 1
Introduced
Jul 27, 2023
Step 2
Referred
Jul 27, 2023
HELP
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill generally limits coverage of generic drugs under federal health care programs to those that are manufactured domestically. Specifically, the bill prohibits coverage of generic drugs that are manufactured in foreign countries under Medicare, Medicaid, the Children's Health Insurance Program (CHIP), TRICARE, and benefits provided by the Veterans' Administration. Coverage is permitted for foreign-made generic drugs if there are fewer than two other generic versions that are manufactured domestically or if the generic versions that are manufactured domestically are in shortage or soon to be discontinued. The Food and Drug Administration (FDA) must notify appropriate agencies about bra...

Provisions · 7 sectionsIntroduced in Senate
Timeline · 2 actions
Jul 27, 2023
Introduced in Senate
Jul 27, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.